Addition of amphotericin B to optisol-GS needs further study

Addition of amphotericin B to optisol-GS needs further study

(HealthDay)—Further investigation of the addition of amphotericin B to Optisol-GS, the most commonly used corneal storage medium in the United States, is warranted, according to research published online Feb. 25 in JAMA Ophthalmology.

Katherine Duncan, M.D., of the University of Maryland School of Medicine in Baltimore, and colleagues conducted an in vitro laboratory efficacy study to identify the lowest concentration of amphotericin B that could be used as supplementation in Optisol-GS to eliminate fungal contaminants. Candida albicans was used to inoculate the vials of Optisol-GS for the efficacy study. In a separate study, the potential toxic effects of amphotericin B to the corneas, with and without light exposure, were assessed.

The researchers found that concentrations of 0.06 and 0.12 µg/mL of amphotericin B added to Optisol-GS eliminated all fungal contaminants by day seven; on day two was reduced by a mean of 3.5 colony-forming units. A concentration of 0.255-µg/mL of amphotericin B added to Optisol-GS eliminated all fungal contaminants by day two. In the safety study, no were observed for corneas stored in Optisol-GS supplemented with amphotericin B, at any concentration, compared with paired controls. No difference was observed in the efficacy or safety of the light-exposed versus light-protected amphotericin B-supplemented Optisol-GS.

"These results do not prove that amphotericin B should be added to Optisol-GS; larger-scale studies and cost-benefit analyses need to be completed," the authors write. "Given the increasing incidence of postkeratoplasty fungal infection, however, the addition of amphotericin B to Optisol-GS deserves further investigation."


Explore further

New anti-microbial compounds evade resistance with less toxicity

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: JAMA Ophthalmology

Copyright © 2016 HealthDay. All rights reserved.

Citation: Addition of amphotericin B to optisol-GS needs further study (2016, February 29) retrieved 22 September 2019 from https://medicalxpress.com/news/2016-02-addition-amphotericin-optisol-gs.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
2 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more